American Portfolios Advisors’s Myriad Genetics MYGN Stock Holding History

American Portfolios Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.28K	Hold	67	–	–	﹤0.01%	3228
2022 Q2	$1.22K	Hold	67	–	–	﹤0.01%	3240
2022 Q1	$1.69K	Hold	67	–	–	﹤0.01%	3264
2021 Q4	$1.85K	Hold	67	–	–	﹤0.01%	3190
2021 Q3	$2.16K	Hold	67	–	–	﹤0.01%	3137
2021 Q2	$2.05K	Hold	67	–	–	﹤0.01%	3142
2021 Q1	$2.04K	Hold	67	–	–	﹤0.01%	2988
2020 Q4	$1.32K	Hold	67	–	–	﹤0.01%	2786
2020 Q3	$874	Sell	67 -58	-46%	-$734	﹤0.01%	2785
2020 Q2	$1.42K	Hold	125	–	–	﹤0.01%	2624
2020 Q1	$1.79K	Hold	125	–	–	﹤0.01%	2437
2019 Q4	$3.4K	Hold	125	–	–	﹤0.01%	2412
2019 Q3	$3.58K	Hold	125	–	–	﹤0.01%	2314
2019 Q2	$3.47K	Hold	125	–	–	﹤0.01%	2304
2019 Q1	$4.15K	Hold	125	–	–	﹤0.01%	2155
2018 Q4	$3.63K	Hold	125	–	–	﹤0.01%	1969
2018 Q3	$5.75K	Hold	125	–	–	﹤0.01%	1954
2018 Q2	$4.67K	Hold	125	–	–	﹤0.01%	2009
2018 Q1	$3.69K	Buy	125 +58	+87%	+$1.96K	﹤0.01%	1976
2017 Q4	$2.3K	Buy	+67	New	+$2.26K	﹤0.01%	2024

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

American Portfolios Advisors's MYGN Position: Q3 2022 in Review

American Portfolios Advisors held its Myriad Genetics (MYGN) position steady in Q3 2022 at 67 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #3228.

American Portfolios Advisors first reported a position in MYGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $5.75K in Q3 2018. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

American Portfolios Advisors held 67 shares of Myriad Genetics worth $1.28K as of Q3 2022.
American Portfolios Advisors left its Myriad Genetics share count unchanged in Q3 2022.
Myriad Genetics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3228 holding.
American Portfolios Advisors first reported a position in Myriad Genetics in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Myriad Genetics position peaked at $5.75K in Q3 2018.
191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.